Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes

Purpose: Previous studies demonstrated that systemic treatment with tauroursodeoxycholic acid (TUDCA) is protective in in vivo mouse models of retinal degeneration and in culture models of hyperglycemia. This study tested the hypothesis that TUDCA will preserve visual and retinal function in a mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jieming, Aung, Moe H., Prunty, Megan C., Hanif, Adam M., Hutson, Lauren M., Boatright, Jeffrey H., Pardue, Machelle T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400977/
https://www.ncbi.nlm.nih.gov/pubmed/34452115
http://dx.doi.org/10.3390/pharmaceutics13081154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400977/
https://www.ncbi.nlm.nih.gov/pubmed/34452115
http://dx.doi.org/10.3390/pharmaceutics13081154

Ejemplares similares